These results indicate that both overexpression and silencing of TDP-43 levels mimic part of the pathological process occurring in neurons with TDP-43 pathology in patient brains, and suggest that both alterations contribute to the development of NPTX2 pathology in TDP-43 proteinopathies. This evidence concerns the gene TARDBP and proteostasis deficiencies.